LivaNova PLC: A Leading Medical Device Company London-based LivaNova PLC is a renowned medical device company that offers therapeutic solutions worldwide. The company operates seamlessly through three primary segments, including Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Under the Cardiopulmonary segment, the company has been involved in researching, developing, manufacturing, and marketing an array of cardiopulmonary products. These life-saving products include oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, and other related products. The Neuromodulation segment of the company has taken a significant leap in researching, developing, and marketing VNS Therapy System, an innovative and implantable device that delivers vagus nerve stimulation (VNS) therapy for drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. The company is also actively involved in developing and testing the VITARIA System, which relies on VNS for treating heart failure. Under its Advanced Circulatory Support segment, the company has been instrumental in developing, producing, and selling temporary life support products. It serves hospitals, healthcare providers, perfusionists, neurologists, neurosurgeons, and other physicians. LivaNova PLC sells its products via independent distributors and direct sales representatives. The company also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and has since delivered top-notch medical solutions worldwide. As a leading medical device company, LivaNova has stayed true to its core goal by consistently researching, developing, and manufacturing cutting-edge medical equipment to save lives.